Login / Signup

Reply to COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.

Chiara CattaneoRoberto CairoliGiuseppe Rossi
Published in: Cancer (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • chronic myeloid leukemia